Home » Watson Lands Deal to Sell Authorized Generic of Pfizer’s Lipitor
Watson Lands Deal to Sell Authorized Generic of Pfizer’s Lipitor
Watson Pharmaceuticals will sell an authorized generic version of Pfizer’s Lipitor when the blockbuster cholesterol drug loses patent exclusivity in the U.S. in November; however, the drug giant is also considering its own OTC version.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
07May
-
14May
-
30May